|
SB 274 - Under this act, the Board of Pharmacy may approve, modify, and establish requirements for pharmacy pilot or demonstration research projects related to technology assisted verification or remote medication dispensing that are designed to enhance patient care or safety, improve patient outcomes, or expand access to pharmacy services. Such pilot or research projects shall be within the scope of the practice of pharmacy, be under the supervision of a Missouri licensed pharmacist, and comply with applicable compliance and reporting as established by the Board. Board approval of such pilot or research projects shall be limited to a period of up to 18 months. The Board may approve an additional 6 month expansion if it is deemed necessary or appropriate to gather or complete research data or if it is deemed to be in the best interests of the patient. The board may rescind approval of a pilot program at any time if it is deemed necessary or appropriate in the interest of patient safety. The provisions of this act will expire on August 28, 2023. The Board shall provide a final report on the approved projects and related data or findings to the General Assembly on or before December 31, 2022. The name, location, approval dates, general description of and responsibilities for an approved pilot project shall be deemed an open record. JOSIE BUTLER
|
